No Prescription |
 |
 | ||
|
Asacol 5 ASA |
|
| ||
No Prescription » Prescription Drugs 2 » Asacol 5 ASA This medication is used to treat ulcerative proctitis a type of bowel disease. It does not cure ulcerative proctitis but it may decrease the number of stools the amount of mucus/blood in the stools and the rectal bleeding caused by irritation/swelling of the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication may also be used for Crohn's disease along with other treatments.How to use Mesalamine RectRead the Patient Information Leaflet available from your pharmacist. Consult your doctor or pharmacist if you have any questions.Use this medication rectally usually once to three times daily or as directed by your doctor. If using this medication once daily use it at bedtime. Dosage is based on your medical condition and response to therapy.This medication works best if you have a bowel movement before using it. Wash your hands before using the medication. Unwrap the suppository right before using. Try to handle it as little as possible because heat from your fingers may cause it to melt. Lie down on your left side with right knee bent. Gently insert the suppository into the rectum with your finger pointed end first. Use a small amount of lubricating gel on the tip of the suppository if desired. Remain lying down for a few minutes. Try to avoid having a bowel movement for 1 to 3 hours keeping the suppository in place so the medicine can work.This medication may stain surfaces that it touches (e.g. clothing floor and counter surfaces).Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time(s) each day.Inform your doctor if your condition persists or worsens. Buy Asacol 5 ASA and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Asacol 5 ASA: Product Type: Prescription Drugs 2 Asacol ( 5-ASA Pentasa Rowasa Generic Mesalamine ) Asacol (5-ASA Pentasa Rowasa Generic Mesalamine) 5-ASA Pentasa Rowasa Generic Mesalamine 500mg 20 suppositories 800mg 90 tablets 180 tablets 400 mg 100 tabs 5-ASA Pentasa Rowasa Generic Mesalamine Asacol
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
